Neurotrope, Inc. Common
NTRP
NTRP was delisted on the 1st of December, 2020.
29 hedge funds and large institutions have $1.04M invested in Neurotrope, Inc. Common in 2019 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 11 reducing their positions, and 13 closing their positions.
13% more call options, than puts
Call options by funds: $205K | Put options by funds: $181K
15% less funds holding
Funds holding: 34 → 29 (-5)
38% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 13
73% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 11
93% less capital invested
Capital invested by funds: $15.3M → $1.04M (-$14.3M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Group One Trading
Chicago,
Illinois
|
+$437K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$325K |
| 3 |
VF
Virtu Financial
New York
|
+$293K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$171K |
| 5 |
Millennium Management
New York
|
+$162K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tanaka Capital Management
New York
|
-$1.52M |
| 2 |
NP
NorthRock Partners
Minneapolis,
Minnesota
|
-$834K |
| 3 |
JMPWA
JP Morgan Private Wealth Advisors
San Francisco,
California
|
-$642K |
| 4 |
MA
MYDA Advisors
Woodmere,
New York
|
-$617K |
| 5 |
Eagle Capital Management (New York)
New York
|
-$479K |
NTRP Hedge Fund Activity: Q3 2019 in Review
29 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Neurotrope, Inc. Common (NTRP) for Q3 2019, worth a combined $1.04M — down 93% from $15.3M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of NTRP and 8 opened new positions — a net loss of 5 holders — while 11 trimmed existing stakes and 3 added.
The largest buyer was Group One Trading, adding an estimated $437K. The largest seller was Tanaka Capital Management, exiting entirely with an estimated $1.52M sold.
- 29 institutional investors held Neurotrope, Inc. Common (NTRP) as of Q3 2019, down from 34 in Q2 2019.
- Funds reported $1.04M of Neurotrope, Inc. Common stock for Q3 2019, down 93% quarter-over-quarter.
- 8 funds opened new Neurotrope, Inc. Common positions in Q3 2019 and 13 closed out, a net change of -5 holders.
- The largest Neurotrope, Inc. Common buyer in Q3 2019 was Group One Trading, an estimated $437K added.
- The largest Neurotrope, Inc. Common seller in Q3 2019 was Tanaka Capital Management, an estimated $1.52M sold.
Based on aggregated 13F filings for Q3 2019.